GE HealthCare Technologies (GEHC) Net Cash Flow Growth (1y) (2023 - 2026)
GE HealthCare Technologies (GEHC) Net Cash Flow Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | -54.17% |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn | 98.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -114.85% |
| Mar 31, 2026 | -394.13% |
| Dec 31, 2025 | 180.79% |
| Sep 30, 2025 | -81.57% |
| Jun 30, 2025 | 334.67% |
| Mar 31, 2025 | -667.95% |
| Dec 31, 2024 | -1,074.19% |
| Sep 30, 2024 | 200.20% |
| Jun 30, 2024 | -38.89% |
| Mar 31, 2024 | -91.09% |
| Dec 31, 2023 | -93.34% |
| Sep 30, 2023 | 50,700.00% |
| Jun 30, 2023 | -1,150.00% |
| Mar 31, 2023 | 1,782.69% |